Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept study
Titel:
Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept study
Auteur:
Pestrin, Marta Bessi, Silvia Puglisi, Fabio Minisini, Alessandro M. Masci, Giovanna Battelli, Nicola Ravaioli, Alberto Gianni, Lorenzo Marsico, Roberta Di Tondini, Carlo Gori, Stefania Coombes, Charles R. Stebbing, Justin Biganzoli, Laura Buyse, Marc Leo, Angelo Di